Cargando…

Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes

BACKGROUND: Disruption of the transforming growth factor-beta (TGF-β) signaling pathway is observed in many cancers, including cervical cancer, resulting in TGF-β resistance. While normal human keratinocytes (HKc) and human papillomavirus type 16-immortalized HKc (HKc/HPV16) are sensitive to the gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Altomare, Diego, Velidandla, Rupa, Pirisi, Lucia, Creek, Kim E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848426/
https://www.ncbi.nlm.nih.gov/pubmed/24047375
http://dx.doi.org/10.1186/1471-2407-13-424
_version_ 1782293755240382464
author Altomare, Diego
Velidandla, Rupa
Pirisi, Lucia
Creek, Kim E
author_facet Altomare, Diego
Velidandla, Rupa
Pirisi, Lucia
Creek, Kim E
author_sort Altomare, Diego
collection PubMed
description BACKGROUND: Disruption of the transforming growth factor-beta (TGF-β) signaling pathway is observed in many cancers, including cervical cancer, resulting in TGF-β resistance. While normal human keratinocytes (HKc) and human papillomavirus type 16-immortalized HKc (HKc/HPV16) are sensitive to the growth inhibitory effects of TGF-β, HKc/HPV16 develop resistance to TGF-β1 as they progress in vitro to a differentiation resistant phenotype (HKc/DR). The loss of sensitivity to the antiproliferative effects of TGF-β1 in HKc/DR is due, at least partially, to decreased expression of the TGF-β receptor type I. In the present study, we explored in detail whether alterations in Smad protein levels, Smad phosphorylation, or nuclear localization of Smads in response to TGF-β could contribute to the development of TGF-β resistance during in vitro progression of HKc/HPV16, and whether TGF-β induction of a Smad-responsive reporter gene was altered in HKc/DR. METHODS: Western blot analysis was used to assess Smad protein levels. In order to study Smad nuclear localization we performed indirect immunofluorescence. In addition, we determined Smad-mediated TGF-β signaling using a luciferase reporter construct. RESULTS: We did not find a decrease in protein levels of Smad2, Smad3 or Smad4, or an increase in the inhibitory Smad7 that paralleled the loss of sensitivity to the growth inhibitory effects of TGF-β1 observed in HKc/DR. However, we found diminished Smad2 phosphorylation, and delayed nuclear Smad3 localization in response to TGF-β1 in HKc/DR, compared to normal HKc and TGF-β sensitive HKc/HPV16. In addition, we determined that TGF-β1 induction of a Smad responsive promoter is reduced by about 50% in HKc/DR, compared to HKc/HPV16. CONCLUSIONS: These results demonstrate that alterations in Smad protein levels are not associated with the loss of response to the antiproliferative effects of TGF-β in HKc/DR, but that diminished and delayed Smad phosphorylation and nuclear localization, and decreased Smad signaling occur in response to TGF-β in HKc/DR.
format Online
Article
Text
id pubmed-3848426
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38484262013-12-04 Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes Altomare, Diego Velidandla, Rupa Pirisi, Lucia Creek, Kim E BMC Cancer Research Article BACKGROUND: Disruption of the transforming growth factor-beta (TGF-β) signaling pathway is observed in many cancers, including cervical cancer, resulting in TGF-β resistance. While normal human keratinocytes (HKc) and human papillomavirus type 16-immortalized HKc (HKc/HPV16) are sensitive to the growth inhibitory effects of TGF-β, HKc/HPV16 develop resistance to TGF-β1 as they progress in vitro to a differentiation resistant phenotype (HKc/DR). The loss of sensitivity to the antiproliferative effects of TGF-β1 in HKc/DR is due, at least partially, to decreased expression of the TGF-β receptor type I. In the present study, we explored in detail whether alterations in Smad protein levels, Smad phosphorylation, or nuclear localization of Smads in response to TGF-β could contribute to the development of TGF-β resistance during in vitro progression of HKc/HPV16, and whether TGF-β induction of a Smad-responsive reporter gene was altered in HKc/DR. METHODS: Western blot analysis was used to assess Smad protein levels. In order to study Smad nuclear localization we performed indirect immunofluorescence. In addition, we determined Smad-mediated TGF-β signaling using a luciferase reporter construct. RESULTS: We did not find a decrease in protein levels of Smad2, Smad3 or Smad4, or an increase in the inhibitory Smad7 that paralleled the loss of sensitivity to the growth inhibitory effects of TGF-β1 observed in HKc/DR. However, we found diminished Smad2 phosphorylation, and delayed nuclear Smad3 localization in response to TGF-β1 in HKc/DR, compared to normal HKc and TGF-β sensitive HKc/HPV16. In addition, we determined that TGF-β1 induction of a Smad responsive promoter is reduced by about 50% in HKc/DR, compared to HKc/HPV16. CONCLUSIONS: These results demonstrate that alterations in Smad protein levels are not associated with the loss of response to the antiproliferative effects of TGF-β in HKc/DR, but that diminished and delayed Smad phosphorylation and nuclear localization, and decreased Smad signaling occur in response to TGF-β in HKc/DR. BioMed Central 2013-09-18 /pmc/articles/PMC3848426/ /pubmed/24047375 http://dx.doi.org/10.1186/1471-2407-13-424 Text en Copyright © 2013 Altomare et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Altomare, Diego
Velidandla, Rupa
Pirisi, Lucia
Creek, Kim E
Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title_full Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title_fullStr Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title_full_unstemmed Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title_short Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes
title_sort partial loss of smad signaling during in vitro progression of hpv16-immortalized human keratinocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848426/
https://www.ncbi.nlm.nih.gov/pubmed/24047375
http://dx.doi.org/10.1186/1471-2407-13-424
work_keys_str_mv AT altomarediego partiallossofsmadsignalingduringinvitroprogressionofhpv16immortalizedhumankeratinocytes
AT velidandlarupa partiallossofsmadsignalingduringinvitroprogressionofhpv16immortalizedhumankeratinocytes
AT pirisilucia partiallossofsmadsignalingduringinvitroprogressionofhpv16immortalizedhumankeratinocytes
AT creekkime partiallossofsmadsignalingduringinvitroprogressionofhpv16immortalizedhumankeratinocytes